Clinical Trials Directory

Trials / Conditions / Resectable Esophageal Squamous Cell Carcinoma

Resectable Esophageal Squamous Cell Carcinoma

7 registered clinical trials studyying Resectable Esophageal Squamous Cell Carcinoma — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingEfficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC
NCT07457528
Tianjin Medical University Cancer Institute and HospitalPhase 2
Not Yet RecruitingStudy of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Ca
NCT06599775
Shanghai Zhongshan HospitalPhase 2
Enrolling By InvitationProspective Cohort Study of Neoadjuvant Therapy With Sintilimab (PD-1 Inhibitor) Combined With Chemotherapy in
NCT06475196
Tang-Du Hospital—
Not Yet RecruitingCadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell Carcinoma
NCT05833971
Guangzhou Institute of Respiratory DiseasePhase 2
UnknownA Phase Ⅱ Clinical Trial of Camrelizumab for Adjuvant Treatment of Resectable Esophageal Squamous Cell Carcino
NCT04533490
The First Affiliated Hospital of Zhengzhou UniversityPhase 2
RecruitingCamrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.
NCT05043688
Zhigang LiPhase 3
CompletedStudy of Tislelizumab in Participants With Resectable Esophageal Squamous Cell Carcinoma
NCT04974047
BeiGenePhase 2